Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 34 for “"FXI"”.
-
The Role of Thrombin Exosites 1 and 2 in the Activation of Factor XI by Thrombin
Factor XI (FXI) is the zymogen of the coagulation protease factor XIa (FXIa) that contributes to thrombin generation through the intrinsic pathway. FXI is activated by the contact pathway protease, factor XIIa (FXIIa), in a high molecular weight kininogen-dependent manner. It is also known to be …
-
FACTOR XI ACTIVATION AND INHIBITION IN CATHETER-INDUCED CLOTTING
… target for anticoagulant therapy because FXI is key for blood clot formation but is not essential in normal blood clotting. Consequently, FXI inhibitors have become a safer alternative to currently available anticoagulants. FXI can be autoactivated by negatively charged surfaces like …
-
Αναστολείς του παράγοντα XI: μια πολλά υποσχόμενη εναλλακτική για την πρόληψη και τη θεραπεία της θρομβοεμβολικής νόσου
… αυτή την κατεύθυνση, η φαρμακευτική αναστολή του FXI φαίνεται ότι αποτελεί πολλά υποσχόμενη θεραπευτική πρακτική που αναμένεται να υπερσκελίσει τους περιορισμούς των διαθέσιμων αντιπηκτικών. Η αισιοδοξία σχετικά με τον FXI ως υποψήφιο θεραπευτικό στόχο περισσότερο από οποιονδήποτε άλλο παράγοντα …
-
Improving Smartphone Interaction in Functionally Illiterate Nigerian Users
… is paramount. However, functionally illiterate (FXI) users, often face significant barriers to engaging with digital interfaces. While Human-Computer Interaction for Development (HCI4D) has proposed inclusive design solutions, research specific to Nigeria remains limited despite only two-thirds …
-
Structural Determinants for Heparin Binding in Human Coagulation Factor XI
… others have demonstrated that zymogen factor XI (FXI) binds to heparin with moderate (KD~110 nM) affinity via residues (K252, K253 and K255) located in the apple 3 (A3) domain of the molecule. In contrast, the enzyme, factor XIa (FXIa), was shown to bind to heparin with significantly higher …
-
LOCALIZATION OF LIGAND-BINDING EXOSITES IN THE CATALYTIC DOMAIN OF FXIa AND DETERMINATION OF THE ROLES OF CALCIUM AND THE HEAVY CHAIN OF FXIa IN FIX ACTIVATION BY FXIa
Coagulation factor XI (FXI) is a plasma zymogen that is activated to FXIa, the catalytic domain of which contains exosites that interact with its normal macromolecular substrate (FIX), and its major regulatory inhibitor (protease nexin-2 kunitz protease inhibitor, PN2KPI). To localize the catalytic …
-
Evaluation of DOAC-Stop to Reverse the Effects of Factor XIa Inhibitors on the Activated Partial Thromboplastin Time
… in hemostasis, but major role in thrombosis. FXI and activated FXI (FXIa) inhibitors are promising alternatives to traditional anticoagulants like vitamin K antagonists and heparins, and newer therapies like direct oral anticoagulants (DOACs), which target thrombin or FXa. Coagulation tests, …
-
Studies on beta 2 glycoprotein I and antiphospholipid antibodies
… procoagulant properties. Beta 2GPI may bind to FXI and serve as a regulator of FXI activation by thrombin. The possible interaction of β2GPI with thrombin is investigated using enzyme linked immunosorbent assays and surface plasmon resonance based studies. It is demonstrated for the first time …
-
Formation of Polyphosphate-Protease-Fibrin Complexes Modulates Protease Function
… This thesis focused on thrombin, factor (F) XI/FXIa, and FXII/FXIIa. Thrombin is the central effector enzyme of coagulation, whereas FXI and FXII are less essential for normal hemostasis but important in thrombosis and contact pathway amplification. Using purified protein systems, surface …
-
Essays on exchange rates and capital flows
… (ii) characterizes optimal FX intervention (FXI) with limited reserves, and (iii) examines the opportunity cost of reserve accumulation from an external balance sheet perspective. Chapter 2 uses security-level holdings of mutual funds and a granular instrumental-variable strategy to identify …
-
Characterization of Prolylcarboxypeptidase Expression Pattern in Rat Cardiomyocytes in Nutrition Overload Conditions
… pathway. The resultant kallikrein will activate FXII which in a reciprocal manner leads to the activation of FXI. Lastly, by metabolizing α-MSH1-13 to an inactive metabolite (α- MSH1-12), PRCP inhibits the anorexigenic response to the endogenous α-MSH1-13, leading to an increase in appetite. …
-
ASSESSING DRUG DEVELOPMENT PROPORTIES OF ANTITHROMBOTIC AND ANTI - CANCER AGENTS
… of evidence have suggested that factor XIa (FXIa) is a promising target for developing a new line of anticoagulants with a potentially minimal risk of bleeding [6, 7]. For example, hemophilia C patients with congenital FXI (Factor XI) deficiency are known to suffer minimal bleeding, and the …
-
Histidine-rich Glycoprotein: A Novel Regulator of Coagulation and Platelets
… a protein present in platelets and plasma, binds FXIIa and inhibits FXII autoactivation and FXIIa-mediated activation of FXI, thereby downregulating thrombosis. HRG binds various ligands, including FXIIa, fibrin(ogen), nucleic acids and polyphosphate (polyP). Studies have shown that polyP, …
-
Role of Neutrophils and NETs in Coagulation
… that NETs promoted clotting independently of FXII, FXI and FVII, and contributed to the formation of a denser clot architecture that is more resistant to lysis. Neutrophils induced blood clotting in a different manner than NETs, more specifically mediated by FXI. Both neutrophils and NETs also …
-
Characterization of the Functional Roles of Histidine-Rich Glycoprotein in Coagulation
… pathway. The intrinsic pathway is initiated when FXII is activated by polyanions such as RNA and DNA, which are released into the blood after cellular activation, injury or death. FXIIa activates FXI, thereby propagating coagulation and leading to thrombin generation and fibrin formation. …
-
Investigations on beta 2-glycoprotein I and antiphospholipid antibodies
… including binding coagulation factor XI (FXI). The implication of the interaction between β2GPI and GPIbα on platelet activation and the release of thromboxane in the presence of anti-β2GPI antibodies is explored, as well as the intracellular pathways via which this activation occurs. The …
-
Αιμοστατικοί δείκτες σε πλασματικά παράγωγα αίματος
… studied were: FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII, fibrinogen, antithrombin (AT) and albumin. Comparison of values between 1 and 5, 1 and 10 and 5 and 10 years of storage was performed. In the second part of the study, a total of 60 plasma units, stored for 11 years (12 units), 7 …
-
The role of hypercoagulability in neurovascular disorders: insights from clinical epidemiology
… Weight Kininogen (HMWK), Prekallikrein (PK), FXI and FXII) and probed their associations with vascular disease phenotypes in a case-control study. In addition to replicating known associations between single genetic variants and contact system factor levels, we identified two novel loci; one …
-
Mechanism of Catheter Thrombosis and Approaches for its Prevention
… pathways which are initiated by fVIIa and fXIIa, respectively. The mechanism by which medical devices initiate clotting is uncertain. Platelet and complement activation and microparticle formation have been implicated, which would drive clotting via the TF pathway. Alternatively, medical …
-
COMPARISON OF THE PROCOAGULANT AND IMMUNOMODULATORY PROPERTIES OF NUCLEAR, MITOCHONDRIAL, AND BACTERIAL DNA WITH RELEVANCE TO SEPSIS
… by addition of corn-trypsin inhibitor and in FXII-depleted plasma, and abolished in FXI-depleted plasma, indicating dependence on the intrinsic pathway of coagulation. Independently of coagulation, DNA from all three sources was capable of causing activation of platelet integrin αIIbβ3. …
Page 1 of 2